Effect of intravitreal ranibizumab and aflibercept injections on retinal nerve fiber layer thickness

Effect of intravitreal ranibizumab and aflibercept injections on retinal nerve fiber layer thickness

Abstract The purpose is to evaluate the effects of multiple intravitreal ranibizumab (IVR) and aflibercept (IVA) injections on peripapillary retinal nerve fiber layer (RNFL) thickness in patients with exudative age-related macular degeneration (AMD). This retrospective, observational, consecutive ca...

Full description

Bibliographic Details
Main Authors:	Jayoung Ahn, Kyuhwan Jang, Joonhong Sohn, Ji In Park, Daniel Duck-Jin Hwang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-84648-1

Similar Items

Effects of Intravitreal Injection of Ranibizumab and Aflibercept on Corneal Endothelium and Central Corneal Thickness
by: Mehmet Coskun
Published: (2018-08-01)

Peripapillary retinal nerve fiber layer thickness in patients with unilateral retinal vein occlusion
by: Jayoung Ahn, et al.
Published: (2021-09-01)

Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
by: Fujii A, et al.
Published: (2014-06-01)

Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.
by: Alexander Tschulakow, et al.
Published: (2014-01-01)

Efficacy of intravitreal injection of Aflibercept vs Ranibizumab in the treatment of diabetic retinopathy
by: Chang Huang, et al.
Published: (2021-05-01)

Assessment of Corneal Sensation, Innervation and Retinal Nerve Fiber Layer in Patients Treated with Multiple Intravitreal Ranibizumab Injections.
by: Gulfidan Bitirgen, et al.
Published: (2017-01-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
by: El-Ashry MF, et al.
Published: (2015-07-01)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017-05-01)

Retinal pigment epithelium tear after intravitreal aflibercept injection
by: Saito M, et al.
Published: (2013-06-01)

Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
by: Beata Urban, et al.
Published: (2020-01-01)

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
by: Yamashita M, et al.
Published: (2014-02-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
by: Norihiro Shimizu, et al.
Published: (2017-01-01)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
by: Miura M, et al.
Published: (2013-08-01)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Kikushima Wataru, et al.
Published: (2020-01-01)

Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
by: Hung-Da Chou, et al.
Published: (2017-06-01)

Intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases
by: Kamran HodjatJalali, et al.
Published: (2017-09-01)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01)

Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections
by: Andrijana Kopić, et al.
Published: (2017-01-01)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Wataru Kikushima, et al.
Published: (2020-01-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
by: Antoine Herbaut, et al.
Published: (2017-01-01)

Erratum to: short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
by: Hung-Da Chou, et al.
Published: (2017-08-01)

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)

Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Aflibercept Injection
by: Kamal Kishore
Published: (2016-09-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01)

Intravitreal aflibercept for ruptured retinal arterial macroaneurysm
by: Zafer Oztas, et al.
Published: (2017-03-01)

Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
by: Yoshihito Sakanishi, et al.
Published: (2021-06-01)

Intravitreal injection of Ranibizumab combined with retinal photocoagulation for CRVO with retinal neovascularization and macular edema
by: Yong Wang
Published: (2018-06-01)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
by: Daniel Sanju Narayan, et al.
Published: (2015-01-01)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021-01-01)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
by: Sam Razavi, et al.
Published: (2021-02-01)

Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model
by: Christoforidis, John Byron, et al.
Published: (2017)

Changes in retinal nerve fiber layer thickness after two intravitreal bevacizumab injections for wet type age-related macular degeneration
by: Morteza Entezari, et al.
Published: (2014-01-01)

Short-term efficacy of intravitreal Aflibercept injection on macular edema secondary to retinal vein occlusion
by: Zhi-Peng Yan, et al.
Published: (2020-07-01)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
by: Elcin Suren, et al.
Published: (2020-01-01)

Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-01-01)

Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_p2p8l1a8cp9rrpsg2up6sk93bb